AMGN
Amgen Inc.NASDAQHealthcare$347.94-1.51%OpenMarket Cap: $187.56B
As of 2026-04-06
Valuation
P/E (TTM)
24.32
PEG
0.27
P/B
21.66
P/S
5.10
EV/EBITDA
12.47
DCF Value
$1,106.39
FCF Yield
4.3%
Div Yield
2.8%
Margins & Returns
Gross Margin
70.5%
Operating Margin
28.0%
Net Margin
21.0%
ROE
96.7%
ROA
15.5%
ROIC
12.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $9.90B | 81.9% | $3.94B | $1.33B | $2.45 | $2.38 |
| FY 2025 | $36.74B | 70.8% | $10.68B | $7.71B | $14.23 | $9.52 |
| Q3 2025 | $9.56B | 67.8% | $2.53B | $3.22B | $5.93 | $2.38 |
| Q2 2025 | $9.17B | 67.2% | $2.64B | $1.43B | $2.65 | $2.38 |
| Q1 2025 | $8.15B | 63.6% | $1.18B | $1.73B | $3.20 | $2.38 |
| Q4 2024 | $9.09B | 65.7% | $2.31B | $627.0M | $1.16 | $2.25 |
| FY 2024 | $33.42B | 61.5% | $7.26B | $4.09B | $7.56 | $9.00 |
| Q3 2024 | $8.50B | 61.1% | $2.05B | $2.83B | $5.22 | $2.25 |
| Q2 2024 | $8.39B | 61.4% | $1.91B | $746.0M | $1.38 | $2.25 |
| Q1 2024 | $7.45B | 57.0% | $991.0M | $-113.0M | $-0.21 | $2.25 |
| Q4 2023 | $8.20B | 62.0% | $1.27B | $767.0M | $1.42 | $2.13 |
| FY 2023 | $28.19B | 70.1% | $7.90B | $6.72B | $12.49 | $8.52 |